Coronary Covered Stents Implantation for the Treatment of Coronary Artery

Clinical Trial Description

This is a pre-market clinical investigation aiming to evaluate the safety and effectiveness of Coronary Covered Stents System for the treatment of coronary artery perforation. ;

Study Design

See also
Status	Clinical Trial	Phase
Completed	`NCT04849169` - Investigation of the Ringer Perfusion Balloon Catheter	N/A
Completed	`NCT04630314` - Covered Stents in Treatment of Coronary Artery Perforation
Completed	`NCT03862352` - Glasgow Natural History Study Of Covered Coronary Interventions

See also

Status

Clinical Trial

Phase

Completed

NCT04849169 - Investigation of the Ringer Perfusion Balloon Catheter

N/A

Completed

NCT04630314 - Covered Stents in Treatment of Coronary Artery Perforation

Completed

NCT03862352 - Glasgow Natural History Study Of Covered Coronary Interventions

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT05398991
Study type	Interventional
Source	Shanghai MicroPort Rhythm MedTech Co., Ltd.
Contact	Ruifen Cao, M.M.
Phone	0086-021-38954600
Email	RuiFen.Cao@microport.com
Status	Recruiting
Phase	N/A
Start date	October 26, 2022
Completion date	July 2025

Coronary Covered Stents Implantation for the Treatment of Coronary Artery Perforation — CONVOY

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms